14 June 2021

Vitamins and minerals: what our body should never be lacking

Vitamins and minerals are essential elements in our diet, and along with carbohydrates, proteins and fats help our body to […]

10 June 2021

Sucrosomial® Iron: new clinical trial performed by Dr. Guillermo Bastida

A new clinical trial entitled “Sucrosomial Iron Supplementation for the Treatment of Iron Deficiency Anemia in Inflammatory Bowel Disease Patients […]

07 April 2021

Post Covid-19 chronic fatigue: new study demonstrates the effects of ApportAL®

PharmaNutra S.p.A. communicates the publication of a new, important scientific study on the use of ApportAL® for the treatment of […]

10 March 2021

Science, medicine and sport: the health of professional athletes (webinar)

Sorry, this entry is only available in Italian. Il via la prossima settimana a “PharmaNutra Sport Attitude”, una serie di […]

15 February 2021

Patient Blood Management: new SIdEM webinar

Sorry, this entry is only available in Italian. PharmaNutra al fianco di SIdEM (SocietĂ  Italiana di Emaferesi e Manipolazione Cellulare) […]

20 January 2021

Stanchezza e dolori muscolari: le cause possibili

Le principali cause della stanchezza cronica e dei dolori muscolari diffusi.
03 November 2020

Launch Cetilar® Tape with menthol: the new Cetilar® line product

Innovative, versatile and easy to apply – available in pharmacies from today – it’s an expansion to the patented Cetylated […]

15 April 2020

Pfizer invests in PharmaNutra’s Sucrosomial® Technology

The innovative Sucrosomial® Magnesium developed by the PharmaNutra Group is one of the main ingredients of the new Multicentrum MyMAG […]

25 March 2020

Two news patents approved in India and USA

The Group obtains approval of the Cetilar® patent in the USA and new prospects unfold for SiderAL® in India thanks to […]

13 December 2019

ASH 2019 Congress: presenting a new study on Sucrosomial® Iron

International recognition continues for PharmaNutra, which, whilst commercially experiencing a strong and constant expansion in foreign markets, also continues, from […]

11 November 2019

PharmaNutra obtains patent for a new composition for treating cardiovascular diseases

The new patent, valid until 2037, opens PharmaNutra up to the possibility of developing specific products for the cardiovascular field, […]

05 November 2019

PharmaNutra obtains the Solid Iron patent for the USA

After Europe, the intellectual property rights of the patent expiring in 2033 are now acknowledged in the United States. A […]

1 2 … 7